Volume 95, Issue 5
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645



Zika virus (ZIKV) is a mosquito-borne flavivirus with a significant public health impact highlighted by the ongoing epidemic in the Americas. We describe a 44-year-old male presenting to our tropical medicine center with complaints of fever, headache, joint pain, and rash after recent travel to Guyana. The patient subsequently developed gait imbalance and lower extremity weakness with clinical examination, cerebrospinal fluid studies, and magnetic resonance imaging of the spine consistent with a diagnosis of Guillain–Barré syndrome (GBS). ZIKV infection was confirmed via detection of ZIKV RNA in urine by polymerase chain reaction. The patient was treated with intravenous immunoglobulin and experienced near-complete neurologic recovery, reporting ongoing mild paresthesia up to 2 months later. This case highlights the diagnostic challenges posed by ZIKV and underscores the need for clinician awareness of the potential for neurological complications such as GBS with ZIKV infection.


Article metrics loading...

Loading full text...

Full text loading...



  1. MacNamara FN, , 1954. Zika virus: a report on three cases of human infection during an epidemic of jaundice in Nigeria. Trans R Soc Trop Med Hyg 48: 139145.[Crossref]
  2. Robin Y, Mouchet J, , 1975. Serological and entomological study on yellow fever in Sierra Leone. Bull Soc Pathol Exot 68: 249258.
  3. Olson JG, Ksiazek TG, Suhandiman Triwibowo, 1981. Zika virus, a cause of fever in Central Java, Indonesia. Trans R Soc Trop Med Hyg 75: 389393.[Crossref]
  4. Jan C, Languillat G, Renaudet J, Robin Y, , 1978. A serological survey of arboviruses in Gabon [in French]. Bull Soc Pathol Exot 71: 140146.
  5. Saluzzo JF, Gonzalez JP, Hervé JP, Georges AJ, , 1981. Serological survey for the prevalence of certain arboviruses in the human population of the south-east area of Central African Republic [in French]. Bull Soc Pathol Exot 74: 490499.
  6. Saluzzo JF, Ivanoff B, Languillat G, Georges AJ, , 1982. Serological survey for arbovirus antibodies in the human and simian populations of the south-east of Gabon [in French]. Bull Soc Pathol Exot 75: 262266.
  7. Duffy MR, Chen TH, Hancock T, Powers AM, Kool JL, Lanciotti RS, Pretrick M, Marfel M, Holzbauer S, Dubray C, Guillaumot L, Griggs A, Bel M, Lambert AJ, Laven J, Kosoy O, Panella A, Biggerstaff BJ, Fischer M, Hayes EB, , 2009. Zika virus outbreak on Yap Island, Federated States of Micronesia. N Engl J Med 360: 25362543.[Crossref]
  8. Oehler E, Watrin L, Larre P, Leparc-Goffart I, Lastere S, Valour F, Baudouin L, Ghawche F, , 2014. Zika virus infection complicated by Guillain-Barré syndrome: case report, French Polynesia, December 2013. Euro Surveill 19: 20720. Available at: http://www.eurosurveillance.org/images/dynamic/EE/V19N09/art20720.pdf.[Crossref]
  9. Guillain G, Barré JA, Strohl A, , 1916. Sur un syndrome de radiculonévrite avec hyperalbuminose du liquide céphalo-rachidien sans réaction cellulaire: remarques sur les caractères cliniques et graphiques des réflexes tendineux. Bull Soc Med Hop Paris 40: 14621470.
  10. Poropatich KO, Walker CL, Black RE, , 2010. Quantifying the association between Campylobacter infection and Guillain-Barré syndrome: a systematic review. J Health Popul Nutr 28: 545552.[Crossref]
  11. Hadden RDM, Karch H, Hartung HP, Zielasek J, Weissbrich B, Schubert J, Weishaupt A, Cornblath DR, Swan AV, Hughes RA, Toyka KV, Plasma Exchange/Sandoglobulin Guillain-Barre Syndrome Trial Group; , 2001. Preceding infections, immune factors, and outcome in Guillain-Barré syndrome. Neurology 56: 758765.[Crossref]
  12. Jacobs BC, Rothbarth PH, van der Meche FGA, Herbrink P, Schmitz PI, de Klerk MA, van Doorn PA, , 1998. The spectrum of antecedent infections in Guillain-Barré syndrome: a case-control study. Neurology 51: 11101115.[Crossref]
  13. Kang JH, Sheu JJ, Lin HC, , 2010. Increased risk of Guillain-Barré syndrome following recent herpes zoster: a population-based study across Taiwan. Clin Infect Dis 51: 525530.[Crossref]
  14. Leis AA, Stokic DS, , 2012. Neuromuscular manifestations of West Nile virus infection. Front Neurol 3: 37.[Crossref]
  15. Ravi V, Taly AB, Shankar SK, Shenoy PK, Nagaraja D, Desai A, Gourie-Devi M, Chandramuki A, , 1994. Association of Japanese encephalitis virus infection with Guillain-Barre syndrome in endemic areas of south India. Acta Neurol Scand 90: 6772.[Crossref]
  16. Lebrun G, Chadda K, Reboux AH, Martinet O, Gaüzère BA, , 2009. Guillain-Barré syndrome after chikungunya infection. Emerg Infect Dis 15: 495496.[Crossref]
  17. Solomon T, Dung NM, Vaughn DW, Kneen R, Thao LT, Raengsakulrash B, Loan HT, Day NP, Farrar J, Myint KS, Warrell MJ, James WS, Nisalak A, White NJ, , 2000. Neurological manifestations of dengue infection. Lancet 355: 10531059.[Crossref]
  18. Pan American Health Organization (PAHO)/World Health Organization (WHO)–Regional Office for the Americas, 2015. Epidemiological Alert: Zika Virus Infection: 7 May 2015. Available at: http://www.paho.org/hq/index.php?option=com_docman&task=doc_view&Itemid=270&gid=30075&lang=e. Accessed June 9, 2016.
  19. Centers for Disease Control and Prevention (CDC), 2016. All Countries and Territories with Active Zika Virus Transmission. Available at: http://www.cdc.gov/zika/geo/active-countries.html. Accessed September 5, 2016.
  20. Centers for Disease Control and Prevention (CDC), 2016. Zika Virus Disease in the United States, 2015–2016. Available at: http://www.cdc.gov/zika/geo/united-states.html. Accessed September 5, 2016.
  21. Ministério da Saúde (Brazil), 2015. Ministério da Saúde divulga novos dados de microcefalia. Available at: http://portalsaude.saude.gov.br/index.php/oministerio/principal/secretarias/svs/noticias-svs/21020-ministerio-da-saude-divulga-novos-dados-demicrocefalia. Accessed June 6, 2016.
  22. Mlakar J, Korva M, Popovic M, Pojsak-Prijatelj M, Mraz J, Kolenc M, Rus KR, Vipotnik TV, Vodusek VF, Vizjak A, Pizem J, Petrovec M, Zupanc TA, , 2016. Zika virus associated with microcephaly. N Engl J Med 374: 951958.[Crossref]
  23. Rasmussen SA, Jamieson DJ, Honein MA, Peterson LR, , 2016. Zika virus and birth defects: reviewing the evidence for causality. N Engl J Med 374: 19811987.[Crossref]
  24. Sejvar JJ, Kohl KS, Gidudu J, Amato A, Bakshi N, Baxter R, Burwen DR, Cornblath DR, Cleerbout J, Edwards KM, Heininger U, Hughes R, Khuri-Bulos N, Korinthenberg R, Law BJ, Munro U, Maltezou HC, Nell P, Oleske J, Sparks R, Velentgas P, Vermeer P, Wiznitzer M, Brighton Collaboration GBS Working Group; , 2011. Guillain-Barré syndrome and Fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine 29: 599612.[Crossref]
  25. Bui YG, Trepanier S, Milord F, Blackburn M, Provost S, Gagnon S, , 2011. Cases of malaria, hepatitis A and typhoid fever among VFRs, Quebec. J Travel Med 18: 373378.[Crossref]
  26. LaRocque RC, Deshpande BR, Rao SR, Brunette GW, Sotir MJ, Jentes ES, Ryan ET, Global TravEpiNet Consortium; , 2013. Pre-travel health care of immigrants returning home to visit friends and relatives. Am J Trop Med Hyg 88: 376380.[Crossref]
  27. Lanciotti RS, Kosoy OL, Laven JJ, Velez JO, Lambert AJ, Johnson AJ, Stanfield SM, Duffy MR, , 2008. Genetic and serologic properties of Zika virus associated with an epidemic, Yap State, Micronesia, 2007. Emerg Infect Dis 14: 12321239.[Crossref]
  28. Centers for Disease Control and Prevention (CDC), 2015. Arboviral Diseases, Neuroinvasive and Non-Neuroinvasive 2015 Case Definition. Available at: https://wwwn.cdc.gov/nndss/conditions/arboviral-diseases-neuroinvasive-and-non-neuroinvasive/case-definition/2015/. Accessed May 4, 2016.
  29. Roze B, Najioullah F, Ferge J, Apetse K, Brouste Y, Cesaire R, Fagour C, Fagour L, Hochedez P, Jeannin S, Joux J, Mehdaoui H, Valentino R, Signate A, Cabie A, GBS Zika Working Group ; , 2016. Zika virus detection in urine from patients with Guillain-Barré syndrome on Martinique, January 2016. Euro Surveill 21: 14.
  30. Gourinat AC, O'Connor O, Calvez E, Goarant C, Dupont-Rouzeyrol M, , 2015. Detection of Zika virus in urine. Emerg Infect Dis 21: 8486.[Crossref]
  31. Korhonen EM, Huhtamo E, Smura T, Kallio-Kokko H, Raassina M, Vapalahti O, , 2016. Zika virus infection in a traveller returning from the Maldives, June 2015. Euro Surveill 21: pii:30107.[Crossref]
  32. Food and Drug Administration (FDA), 2016. Emergency Use Authorizations: Zika Virus Emergency Use Authorization. Available at: http://www.fda.gov/MedicalDevices/Safety/EmergencySituations/ucm161496.htm#zika. Accessed June 6, 2016.
  33. Bingham AM, Cone M, Mock V, Heberlein-Larson L, Stanek D, Blackmore C, Likos A, , 2016. Comparison of test results for Zika virus RNA in urine, serum, and saliva specimens from persons with travel-associated Zika virus disease: Florida, 2016. MMWR 65: 475478.
  34. Cao-Lormeau VM, Blake A, Mos S, Lastere S, Roche C, Vanhomwegen J, Dub T, Baudouin L, Teissier A, Larre P, Vial AL, Decam C, Choumet V, Halstead SK, Willison HJ, Musset L, Manuguerra JC, Despres P, Fournier E, Mallet HP, Musso D, Fontanet A, Neil J, Ghawche F, , 2016. Guillain-Barre syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study. Lancet 387: 15311539.[Crossref]
  35. Fokke C, van den Berg B, Drenthen J, Walgaard C, van Doorn PA, Jacobs BC, , 2014. Diagnosis of Guillain-Barré syndrome and validation of Brighton criteria. Brain 137: 3343.[Crossref]
  36. Hughes RAC, Wijdicks EF, Benson E, Cornblath DR, Hahn AF, Meythaler JM, Sladky JT, Barohn RJ, Stevens JC, Multidisciplinary Consensus Group; , 2005. Supportive care for patients with Guillain-Barré syndrome. Arch Neurol 62: 11941198.[Crossref]

Data & Media loading...

  • Received : 17 May 2016
  • Accepted : 21 Sep 2016

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error